A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Paroxetine Impurity 28 | Paroxetine Impurity 28. Uses: For analytical and research use. CAS No. 105812-81-5. Molecular formula: C13H18FNO. Mole weight: 223.29. Catalog: APB105812815. |  |
| Paroxetine Impurity 29 | Paroxetine Impurity 29. Uses: For analytical and research use. CAS No. 127017-78-1. Molecular formula: C14H21NO2. Mole weight: 235.33. Catalog: APB127017781. | |
| Paroxetine Impurity 3 | Paroxetine Impurity 3. Uses: For analytical and research use. CAS No. 324023-99-6. Molecular formula: C20H23NO3. Mole weight: 325.4. Catalog: APB324023996. | |
| Paroxetine Impurity 30 | Paroxetine Impurity 30. Uses: For analytical and research use. CAS No. 127017-41-8. Molecular formula: C21H26ClNO4. Mole weight: 391.89. Catalog: APB127017418. | |
| Paroxetine Impurity 31 | Paroxetine Impurity 31. Uses: For analytical and research use. CAS No. 2361294-43-9. Molecular formula: C19H19FN2O4. Mole weight: 358.37. Catalog: APB2361294439. | |
| Paroxetine Impurity 4 | Paroxetine Impurity 4. Uses: For analytical and research use. CAS No. 608521-21-7. Molecular formula: C14H20FNO3S. Mole weight: 301.38. Catalog: APB608521217. | |
| Paroxetine Impurity 5 | Paroxetine Impurity 5. Uses: For analytical and research use. CAS No. 100332-20-5. Molecular formula: C13H18FNO. Mole weight: 223.29. Catalog: APB100332205. | |
| Paroxetine Impurity 6 | Paroxetine Impurity 6. Uses: For analytical and research use. CAS No. 100332-12-5. Molecular formula: C13H18FNO. Mole weight: 223.29. Catalog: APB100332125. | |
| Paroxetine Impurity 7 | Paroxetine Impurity 7. Uses: For analytical and research use. CAS No. 50373-13-2. Molecular formula: C13H19NO. Mole weight: 205.3. Catalog: APB50373132. | |
| Paroxetine Impurity 9 | Paroxetine Impurity 9. Uses: For analytical and research use. CAS No. 253768-88-6. Molecular formula: C26H24FNO5. Mole weight: 449.48. Catalog: APB253768886. | |
| Paroxetine Impurity G HCl | An impurity of Paroxetine which is an antidepressant to treat diseases like depression, obsessive-compulsive disorder, anxiety disorders. Alternative Names: 4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine Hydrochloride; 4-(4-Fluorophenyl)-1,2,3,6-tetrahydro-1-methylpyridine Hydrochloride; 1-Methyl-4-(4'-fluorophenyl)-1,2,3,6-tetrahydropyridine Hydrochloride; Paroxetine EP Impurity G. Grades: > 95%. CAS No. 1012886-75-7. Molecular formula: C12H14FN.HCl. Mole weight: 227.71. |  |
| Paroxetine maleate | Paroxetine maleate. Group: Biochemicals. Grades: Purified. CAS No. 64006-44-6. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| Paroxetine maleate | Paroxetine maleate is a selective inhibitor of serotonin reuptake and an antidepressant. Category: Active pharmaceutical ingredients. CAS No. 64006-44-6. Product ID: API64006446. Molecular formula: C23H24FNO7. Mole weight: 445.443. |  |
| Paroxetine maleate | Paroxetine maleate is a highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki = 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Alternative Names: (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine maleate; BRL-29060; FG-7051; BRL 29060; FG 7051; BRL29060; FG7051. Grades: ≥99% by HPLC. CAS No. 64006-44-6. Molecular formula: C19H20FNO3.C4H4O4. Mole weight: 445.44. | |
| Paroxetine Mesylate | An impurity of Paroxetine which is a selective serotonin reuptake inhibitor. Alternative Names: Paroxetine Mesylate; 217797-14-3; Paroxetine Mesilate; POT.mes; Paroxetine methanesulfonate; Brisdelle; Mesafem; Pexeva; Paroxetine methanesulphonate; LDMP; PO-T.MES; M711N184JE; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine methanesulfonate; Paroxetine Mesylate [USAN]; UNII-M711N184JE; Paroxetine mesylate (USAN);(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Mesylate; (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinemethanesulfonate; (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidin-1-ium; methanesulfonate; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-,(3S,4R)-, Methanesulfonate. Grades: > 95%. CAS No. 217797-14-3. Molecular formula: C19H20FNO3.CH4O3S. Mole weight: 425.48. | |
| Paroxetine Mesylate | Paroxetine Mesylate is the mesylate salt of paroxetine, a selective serotonin reuptake inhibitor (SSRI) of the phenylpiperidine class. The mesylate salt form provides enhanced aqueous solubility compared to paroxetine hydrochloride. Paroxetine is the most potent SSRI in terms of serotonin transporter (SERT) binding affinity. Applications: Indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder. paroxetine mesylate is the most potent ssri in serotonin transporter binding affinity, providing robust and sustained serotonin reuptake inhibition. Category: Active pharmaceutical ingredients. Synonyms: (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine methanesulfonate;Paroxetine-002-SR-Salt. CAS No. 217797-14-3. Product ID: API217797143. Molecular formula: C20H24FNO6S. Mole weight: 425.5. InChIKey: SHIJTGJXUHTGGZ-RVXRQPKJSA-N. | |
| Paroxetine Related Compound F | Paroxetine Related Compound F. Uses: For analytical and research use. CAS No. 110429-36-2. Mole weight: 343.39. Catalog: AP110429362. | |
| PAROXETINE RELATED COMPOUND F (10 MG) (TRANS(-)-1-METHYL-3-[(1,3-BENZODIOXOL-5-YLOXY)-METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE) | PAROXETINE RELATED COMPOUND F (10 MG) (TRANS(-)-1-METHYL-3-[(1,3-BENZODIOXOL-5-YLOXY)-METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE). Product ID: ACMA00011110. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Paroxetine USP Related Compound F | Paroxetine USP Related Compound F. Uses: For analytical and research use. CAS No. 110429-36-2. Molecular formula: C20H22FNO3. Mole weight: 343.4. Catalog: APB110429362. | |
| Paroxetine USP Related Compound G | Paroxetine USP Related Compound G. Uses: For analytical and research use. CAS No. 1217655-87-2. Molecular formula: C25H25ClFNO3. Mole weight: 441.93. Catalog: APB1217655872. | |
| Paroxol methanesulfonate | Paroxol methanesulfonate is an intermediate in the synthesis of Paroxetine, a selective serotonin reuptake inhibitor. Category: Active pharmaceutical ingredients. CAS No. 608521-21-7. Product ID: API608521217. Molecular formula: C14H20FNO3S. Mole weight: 301.38. | |
| Paroxol Methanesulfonate | An intermediate in the synthesis of Paroxetine, a selective serotonin reuptake inhibitor. Group: Biochemicals. Alternative Names: (3S,4R)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol Methanesulfonate. Grades: Highly Purified. CAS No. 608521-21-7. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Paroxol tosylate | Paroxol tosylate. Group: Biochemicals. Alternative Names: (3S,4R)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol tosylate; (3S,4R)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol 3- (4-methyl Benzene sulfonate). Grades: Highly Purified. CAS No. 317323-77-6. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C20H24FNO3S. US Biological Life Sciences. | Worldwide |
| PARP10/15-IN-1 | PARP10/15-IN-1 (compound 8l) is a potent inhibitor of dual inhibitor of PARP10 and PARP15, with IC50s of 160 nM and 370 nM, respectively. PARP10/15-IN-1 can be used for cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2892065-01-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-143398. |  |
| PARP11 inhibitor ITK7 | PARP11 inhibitor ITK7 (ITK7) is a potent and selective PARP11 inhibitor. PARP11 inhibitor ITK7 can potently inhibit PARP11 with an IC50 value of 14 nM. PARP11 inhibitor ITK7 can be used for the research of cellular localization[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ITK7. CAS No. 2411890-36-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-125218. | |
| PARP1/2/TNKS1/2-IN-1 | PARP1/2/TNKS1/2-IN-1 (Compound I-9) is a dual PARP-1, PARP-2, TNKS1 and TNKS2 inhibitor with IC50 values of 0.25 nM, 1.2 nM, 13.5 nM and 4.15 nM against PARP-1, PARP-2, TNKS1 and TNKS2, respectively. PARP1/2/TNKS1/2-IN-1 exhibits favorable synergistic antitumor efficacy and induces apoptosis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2243453-32-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-146336. | |
| PARP14 inhibitor H10 | PARP14 inhibitor H10, compound H 10, is a selective inhibitor against PARP14 (IC50=490 nM), over other PARPs (?24 fold over PARP1). PARP14 inhibitor H10 induces caspase-3/7-mediated cell apoptosis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2084811-68-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-117889. | |
| PARP1 Antibody [N4A5] | PARP,PARP1. Group: Antibodies. Alternative Names: PARP,PARP1. Pack Sizes: 20ul. Product ID: F0148. Storage Conditions: -20ยฐC (avoid freeze-thaw cycles), 2 years. |  United States; Europe |
| PARP-1-IN-2 | PARP-1-IN-2 (compound 11g) is a potent PARP1 inhibitor, with an IC50 of 149 nM, and ADME prediction indicates it has high blood-brain barrier permeability. PARP1-IN-2 shows significantly potent anti-proliferative activity against Human lung adenocarcinoma epithelial cell line A549. PARP1-IN-2 can induce A549 cells apoptosis[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 684234-55-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-147027. | |
| PARP1-IN-56 | PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP-ribose) polymerase (PARP1) inhibitor. PARP1-IN-56 can be radiolabeled with 211At or 125I for use as an α-emitting radiotherapeutic agent. PARP1-IN-56 can be used for the research of cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1574367-80-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-182499. | |
| PARP7-IN-15 | PARP7-IN-15 is an orally active and selective PARP7 inhibitor with an IC50 of 0.56 nM. PARP7-IN-15 inhibits the enzymatic activity of PARP7 and induces anti-tumor activity against lung cancer in vivo. PARP7-IN-15 can be used for the research of lung cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2819998-97-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-155351. | |
| PARP7-IN-16 free base | PARP7-IN-16 free base is the free base form of PARP7-IN-16 (HY-156419). PARP7-IN-16 free base is a selective and orally active inhibitor of PARP-1/2/7, with IC50s of 0.94, 0.87 and 0.21 nM, respectively. PARP7-IN-16 can be used for the research of breast cancer and prostate cancer[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2136325-05-6. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-156419A. | |
| PARP7-IN-17 | PARP7-IN-17 is a potent inhibitor of PARP7 with IC50 of 4.5 nM that has oral bioavailability. PARP7-IN-17 displays antitumor effect[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 3024030-10-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-163081. | |
| PARP7-IN-22 | PARP7-IN-22 (XLY-1) is a PARP7 inhibitor with an IC50 of 0.6 nM. PARP7-IN-22 (XLY-1) is orally active, enhances type I interferon signaling in vitro, restores type I interferon signaling, promotes T cell infiltration into tumor tissues, and significantly inhibits tumor growth. PARP7-IN-22 shows promise for research in the field of cancer immunotherapy[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2946705-91-3. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-163719. | |
| PARPi-FL | PARPi-FL is an agent of fluorescent PARP imaging. In vitro, it is capable of detecting the target engagement of a PARP inhibitor panel. Category: Active pharmaceutical ingredients. Synonyms: Olaparib-bodipy FL,Olaparib bodipy FL. CAS No. 1380359-84-1. Product ID: API1380359841. Molecular formula: C34H32BF3N6O3. Mole weight: 640.46. | |
| PARPi-FL | PARPi-FL (Olaparib-bodipy FL) is a small-molecule fluorescent inhibitor of PARP1 that can specifically bind to PARP1. PARPi-FL can be used as a fluorescent imaging agent for tumor detection, diagnosis, and surgical guidance[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Olaparib-bodipy FL. CAS No. 1380359-84-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-120115. | |
| PARPYnD | PARPYnD is a PARP enzyme photoaffinity probe (AfBP) based on the triple PARP1/2/6 inhibitor AZ9482 (HY-119653), which induces breast cancer Formation of multipolar spindles (MPS) in cells. PARPYnD inhibits PAPR wih IC50 of 38 nM (PARP1), 6 nM (PARP2), 230 nM (PARP6), respectively. PARPYnD enriches recombinant PARP6 incorporated into cell lysates and inhibits PARP6 in cell-free assays, but it does not label PARP6 in intact cells[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2561483-27-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-145749. | |
| Parsaclisib | Parsaclisib (INCB050465) is a potent, selective and orally active inhibitor of PI3Kδ, with an IC50 of 1 nM at 1 mM ATP. Parsaclisib shows approximately 20000-fold selectivity over other PI3K class I isoforms. Parsaclisib can be used for the research of relapsed or refractory B-cell malignancies[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: INCB050465; IBI-376. CAS No. 1426698-88-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109068. | |
| Parsaclisib hydrochloride | Parsaclisib hydrochloride (INCB050465 hydrochloride) is a potent, selective and orally active inhibitor of PI3Kδ, with an IC50 of 1 nM at 1 mM ATP. Parsaclisib hydrochloride shows approximately 20000-fold selectivity over other PI3K class I isoforms. Parsaclisib hydrochloride can be used for the research of relapsed or refractory B-cell malignancies[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: INCB050465 hydrochloride; IBI-376 hydrochloride. CAS No. 1995889-48-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109068A. | |
| p-Arsanilic acid | p-Arsanilic acid. CAS No: 98-50-0 |  Sarchem Laboratories New Jersey NJ |
| p-Arsanilic acid | 100g Pack Size. Group: Building Blocks, Organics. Formula: C6H8AsNO3. CAS No. 98-50-0. Prepack ID 31968396-100g. Molecular Weight 217.05. See USA prepack pricing. |  |
| Parsatuzumab | Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Anti-EGFL7; RG 7414. CAS No. 1312797-14-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99215. | |
| Parsley Leaf Powder | Parsley Leaf Powder. |  CA, FL & NJ |
| Parsley Seed Oil | Parsley Seed Oil. CAS No. 8000-68-8. FEMA No. 2836. Kosher: Y. VIGON Item # 500783. Categories: Speciality Ingrdients Suppliers, Flavors, Fragrances, Perfumers. |  America & Internationally |
| Parstatin (human) | Parstatin is a 41-amino acid peptide, formed by proteolytic cleavage on activation of the protease activated receptor-1, with antiangiogenic properties. Parstatin (human) attenuates endothelial cell migration and proliferation (IC50 ~ 3 μM), and induces cell cycle arrest. It promotes activation of caspase-3 and exhibits pro-apoptotic activity in vitro. Alternative Names: H-Met-Gly-Pro-Arg-Arg-Leu-Leu-Leu-Val-Ala-Ala-Cys-Phe-Ser-Leu-Cys-Gly-Pro-Leu-Leu-Ser-Ala-Arg-Thr-Arg-Ala-Arg-Arg-Pro-Glu-Ser-Lys-Ala-Thr-Asn-Ala-Thr-Leu-Asp-Pro-Arg-OH; L-methionyl-glycyl-L-prolyl-L-arginyl-L-arginyl-L-leucyl-L-leucyl-L-leucyl-L-valyl-L-alanyl-L-alanyl-L-cysteinyl-L-phenylalanyl-L-seryl-L-leucyl-L-cysteinyl-glycyl-L-prolyl-L-leucyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-threonyl-L-arginyl-L-alanyl-L-arginyl-L-arginyl-L-prolyl-L-alpha-glutamyl-L-seryl-L-lysyl-L-alanyl-L-threonyl-L-asparagyl-L-alanyl-L-threonyl-L-leucyl-L-alpha-aspartyl-L-prolyl-L-arginine. Grades: ≥98%. CAS No. 1065755-99-8. Molecular formula: C191H330N64O53S3. Mole weight: 4467.29. | |
| Parstatin (mouse) | Parstatin, a 41-mer peptide which is cleaved upon activation of Proteinase-Activated Receptor 1, attenuates endothelial cell migration and proliferation (IC50 ~ 20 μM), and induces cell cycle arrest. It promotes activation of caspase-3 and exhibits pro-apoptotic activity in vitro. Alternative Names: H-Met-Gly-Pro-Arg-Arg-Leu-Leu-Ile-Val-Ala-Leu-Gly-Leu-Ser-Leu-Cys-Gly-Pro-Leu-Leu-Ser-Ser-Arg-Val-Pro-Met-Ser-Gln-Pro-Glu-Ser-Glu-Arg-Thr-Asp-Ala-Thr-Val-Asn-Pro-Arg-OH; L-methionyl-glycyl-L-prolyl-L-arginyl-L-arginyl-L-leucyl-L-leucyl-L-isoleucyl-L-valyl-L-alanyl-L-leucyl-glycyl-L-leucyl-L-seryl-L-leucyl-L-cysteinyl-glycyl-L-prolyl-L-leucyl-L-leucyl-L-seryl-L-seryl-L-arginyl-L-valyl-L-prolyl-L-methionyl-L-seryl-L-glutaminyl-L-prolyl-L-alpha-glutamyl-L-seryl-L-alpha-glutamyl-L-arginyl-L-threonyl-L-alpha-aspartyl-L-alanyl-L-threonyl-L-valyl-L-asparagyl-L-prolyl-L-arginine. Grades: ≥98%. CAS No. 1065756-01-5. Molecular formula: C189H326N58O57S3. Mole weight: 4419.19. | |
| Parthenolide | 500mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C15H20O3. CAS No. 20554-84-1. Prepack ID 73041456-500mg. Molecular Weight 248.32. See USA prepack pricing. | |
| Parthenolide | Parthenolide. Group: Biochemicals. Grades: Purified. CAS No. 20554-84-1. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Parthenolide | Parthenolide is a sesquiterpene lactone found in the medicinal herb Feverfew. Parthenolide exhibits anti-inflammatory activity by inhibiting NF-κB activation; also inhibits HDAC1 protein without affecting other class I/II HDACs. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (-)-Parthenolide. CAS No. 20554-84-1. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-N0141. | |
| Parthenolide | (-)-Parthenolide is a sesquiterpene lactone which occurs naturally in the plant feverfew (Tanacetum parthenium) and also promotes the ubiquitination of MDM2 and activates p53 cellular functions. Uses: 5-ht antagonist; anti-tumor; anti-cancer; antimycobacterial; anti-inflammatory. Alternative Names: NSC-157035; NSC 157035; NSC157035. Grades: >98%. CAS No. 20554-84-1. Molecular formula: C15H20O3. Mole weight: 248.32. | |
| Parthenolide (Standard) | Parthenolide (Standard) is the analytical standard of Parthenolide. This product is intended for research and analytical applications. Parthenolide is a sesquiterpene lactone found in the medicinal herb Feverfew. Parthenolide exhibits anti-inflammatory activity by inhibiting NF-κB activation; also inhibits HDAC1 protein without affecting other class I/II HDACs. Uses: Scientific research. Category: Signaling pathways. Alternative Names: (-)-Parthenolide (Standard). CAS No. 20554-84-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0141R. | |
| Parthenosin | Parthenosin is a natural compound which can be used in content analysis, pharmacological experiments, activity screening, etc. Grades: 98%. CAS No. 166196-16-3. Molecular formula: C25H26O13. Mole weight: 534.47. | |
| Partially Hydrolysed Polyvinyl Alcohol | Partially Hydrolysed Polyvinyl Alcohol. CAS No. 25213-24-5. Cenik is your partner of choice for specialised chemicals. We don't just provide products - we supply solutions to your technical and regulatory specifications. |  |
| Parvisporin | It is a neuritogenic agent produced by the strain of Stachyborrys parvispora F4708. It promotes the enlargement of the neural sinus of P12 cells, and the effect of Stachybotrin C is obvious, but the effect of Parvisporin is weak. Molecular formula: C23H34O5. Mole weight: 390.51. | |
| Parvodicin A | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. Alternative Names: Ristomycin A aglycone, 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-(2-deoxy-2-((1-oxodecyl)amino)-beta-D-glucopyranuronosyl)-42-O-alpha-D-mannopyranosyl-N15-methyl-. CAS No. 110882-81-0. Molecular formula: C81H84N8O29Cl2. Mole weight: 1704.48. | |
| Parvodicin B1 | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. The terminal branching activity of lipid chains is greater than straight chains (C1>C2>C3>C4, B1>B2), and the chain length is greater than short chains (C2>B). It acts by inhibiting the synthesis of bacterial cell wall. Alternative Names: Antibiotic A-40926 A0; Ristomycin A aglycone, 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-(2-deoxy-2-((9-methyl-1-oxodecyl)amino)-beta-D-glucopyranuronosyl)-42-o-alpha-D-mannopyranosyl-N15-methyl-. CAS No. 110882-82-1. Molecular formula: C82H86N8O29Cl2. Mole weight: 1718.50. | |
| Parvodicin B2 | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. The terminal branching activity of lipid chains is greater than straight chains (C1>C2>C3>C4, B1>B2), and the chain length is greater than short chains (C2>B). It acts by inhibiting the synthesis of bacterial cell wall. Alternative Names: Antibiotic A-40926 A1; Antibiotic A 40926 factor A; Antibiotic A 40926A; Ristomycin A aglycone, 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-(2-deoxy-2-((1-oxoundecyl)amino)-beta-D-glucopyranuronosyl)-42-o-alpha-D-mannopyranosyl-N15-methyl-. CAS No. 110882-83-2. Molecular formula: C82H86N8O29Cl2. Mole weight: 1718.50. | |
| Parvodicin C1 | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. Parvodicin C1 and C2 have stronger antibacterial effects than Parvodicin C3 and C4. The antibacterial activity of Parvodicin C is 1-4 times stronger than Tecomycin and 2-4 times stronger than vancomycin. The terminal branching activity of lipid chains is greater than straight chains (C1>C2>C3>C4, B1>B2), and the chain length is greater than short chains (C2>B). The half-life of Parvodicin C1 is longer in vivo than vancomycin and Archeomycin. Alternative Names: Ristomycin A aglycone, 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-b-D-glucopyranuronosyl]-42-O-a-D-mannopyranosyl-N15-methyl-; A 40926B; A 40926 B0; Antibiotic A 40926 factor B0; Antibiotic A 40926B. CAS No. 110882-84-3. Molecular formula: C83H88N8O29Cl2. Mole weight: 1732.53. | |
| Parvodicin C2 | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. Parvodicin C1 and C2 have stronger antibacterial effects than Parvodicin C3 and C4. The antibacterial activity of Parvodicin C is 1-4 times stronger than Tecomycin and 2-4 times stronger than vancomycin. The terminal branching activity of lipid chains is greater than straight chains (C1>C2>C3>C4, B1>B2), and the chain length is greater than short chains (C2>B). The half-life of Parvodicin C1 is longer in vivo than vancomycin and Archeomycin. Alternative Names: Antibiotic A-40926 B1; Ristomycin A aglycone, 5,31-dichloro-7-demethyl-64-O-demethyl-19-deoxy-56-O-(2-deoxy-2-((1-oxododecyl)amino)-beta-D-glucopyranuronosyl)-42-o-alpha-D-mannopyranosyl-N15-methyl-. CAS No. 110882-85-4. Molecular formula: C83H88N8O29Cl2. Mole weight: 1732.53. | |
| Parvodicin complex | It is produced by the strain of Actinomadura paroosalo. It's a glycopeptide antibiotic. It has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and enterococcus faecalis. Parvodicin C1 and C2 have stronger antibacterial effects than Parvodicin C3 and C4. The antibacterial activity of Parvodicin C is 1-4 times stronger than Tecomycin and 2-4 times stronger than vancomycin. The terminal branching activity of lipid chains is greater than straight chains (C1>C2>C3>C4, B1>B2), and the chain length is greater than short chains (C2>B). The half-life of Parvodicin C1 is longer in vivo than vancomycin and Archeomycin. Alternative Names: A 40926 complex. Grades: >95% by HPLC. CAS No. 187888-13-7. Molecular formula: C83H88Cl2N8O29 (for C1). Mole weight: 1732.53. | |
| Parylene f | Parylene f. Alternative Names: Dimer,Parylene F;5,6,11,12,13,14,15,16-Octafluorotricyclo[8.2.2.24,7]hexadeca-4,6,10,12,13,15-hexaene;Parylene F Dimer. CAS No. 1785-64-4. Molecular formula: C16H8F8. Mole weight: 352.22g/mol. IUPAC Name: 5,6,11,12,13,14,15,16-octafluorotricyclo[8.2.2.24,7]hexadeca-1(12),4(16),5,7(15),10,13-hexaene. SMILES: C1CC2=C(C(=C(CCC3=C(C(=C1C(=C3F)F)F)F)C(=C2F)F)F)F. InChI: InChI=1S/C16H8F8/c17-9-5-1-2-6-11(19)15(23)8(16(24)12(6)20)4-3-7(13(9)21)14(22)10(5)18/h1-4H2. |  |
| Pascolizumab | Pascolizumab (SB-240683) is a humanized anti-IL-4 monoclonal antibody. Pascolizumab has the potential for the research of asthma[1]. Uses: Scientific research. Category: Inhibitory antibodies. Alternative Names: SB-240683. CAS No. 331243-22-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-P99801. | |
| Pashanone | Formula: Group: Biochemicals. Grades: Plant Grade. CAS No. 42438-78-8. Pack Sizes: 5mg, 10mg. US Biological Life Sciences. | Worldwide |
| Pasireotide | Pasireotide (SOM230), a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide also exhibits antisecretory, antiproliferative, and proapoptotic activity[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SOM230. CAS No. 396091-73-9. Pack Sizes: 10 mM * 1 mL in Water; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-16381. | |
| Pasireotide | Pasireotide pamoate, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. Alternative Names: Pasireotide; SOM230; SOM-203; SOM 203; Signifor. Grades: >98%. CAS No. 396091-73-9. Molecular formula: C58H66N10O9. Mole weight: 1047.227. | |
| Pasireotide | Pasireotide is a stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors. Category: Active pharmaceutical ingredients. CAS No. 396091-73-9. Product ID: API396091739. Molecular formula: C58H66N10O9. Mole weight: 1047.206. | |
| Pasireotide acetate | Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide acetate can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide acetate also exhibits antisecretory, antiproliferative, and proapoptotic activity[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: SOM230 acetate. CAS No. 396091-76-2. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16381A. | |
| Pasireotide acetate | Pasireotide acetate is a cyclic peptide, which can improve agonist activity at somatostatin receptors. Alternative Names: Pasireotide acetate salt; SOM230 acetate. Grades: 98%. CAS No. 396091-76-2. Molecular formula: C60H70N10O11. Mole weight: 1107.26. | |
| Pasireotide Diaspartate | Pasireotide is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It is a somatostatin receptor (SSTR) agonist with selectively for SST1, SST2, SST3, and SST5 over SST4 (IC50s = 9.3, 1, 1.5, 0.16, and >100 nM, respectively, for human recombinant receptors). Uses: Hormones. Alternative Names: SOM230. Grades: ≥95%. CAS No. 820232-50-6. Molecular formula: C58H66N10O9ยท2C4H7NO4. Mole weight: 1313.41. | |
| Pasireotide ditrifluoroacetate | Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. Alternative Names: Pasireotide TFA salt; SOM230 TFA salt; SOM-230 TFA salt; SOM 230 TFA salt; SOM230 ditrifluoroacetate; SOM-230 ditrifluoroacetate; SOM 230 ditrifluoroacetate. Molecular formula: C62H68F6N10O13. Mole weight: 1275.3. | |
Our database is helping our users find suppliers everyday.
